Skip to main content
. 2011 Apr 8;70(7):1208–1215. doi: 10.1136/ard.2011.153023

Figure 3.

Figure 3

Serum infliximab levels in (A) tumour necrosis factor alpha (TNF)-low, (B) TNF-int and (C) TNF-high patients. Patients were divided into three groups by the plasma TNF level before infliximab therapy (baseline-TNF) as follows: TNF-low patients, less than 0.55 pg/ml; TNF-int patients, 0.55 pg/ml or greater to less than 1.65 pg/ml; and TNF-high patients, 1.65 pg/ml or greater. Serum infliximab levels were measured by ELISA.